These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. An audit of pain management in acute sickle cell crisis. Day J Nurs Times; 1997 Jan 8-14; 93(2):33-4. PubMed ID: 9016123 [TBL] [Abstract][Full Text] [Related]
30. Management of painful vaso-occlusive crisis of sickle-cell anemia: consensus opinion. Mousa SA; Al Momen A; Al Sayegh F; Al Jaouni S; Nasrullah Z; Al Saeed H; Alabdullatif A; Al Sayegh M; Al Zahrani H; Hegazi M; Al Mohamadi A; Alsulaiman A; Omer A; Al Kindi S; Tarawa A; Al Othman F; Qari M Clin Appl Thromb Hemost; 2010 Aug; 16(4):365-76. PubMed ID: 20530056 [TBL] [Abstract][Full Text] [Related]
31. Impact of individualized pain plan on the emergency management of children with sickle cell disease. Krishnamurti L; Smith-Packard B; Gupta A; Campbell M; Gunawardena S; Saladino R Pediatr Blood Cancer; 2014 Oct; 61(10):1747-53. PubMed ID: 24962217 [TBL] [Abstract][Full Text] [Related]
33. Sickle cell disease: time for a closer look at treatment options? Sheth S; Licursi M; Bhatia M Br J Haematol; 2013 Aug; 162(4):455-64. PubMed ID: 23772687 [TBL] [Abstract][Full Text] [Related]
34. Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell disease. Ender KL; Krajewski JA; Babineau J; Tresgallo M; Schechter W; Saroyan JM; Kharbanda A Pediatr Blood Cancer; 2014 Apr; 61(4):693-6. PubMed ID: 24249617 [TBL] [Abstract][Full Text] [Related]
35. Feasibility and benefit of hydroxycarbamide as a long-term treatment for sickle cell disease patients: results from the North West London Sickle Cell Disease Registry. Gilmore A; Cho G; Howard J; Layton M; Afif M; Hughes RG; Philpott NJ; Patankar S; Davies SC; Am J Hematol; 2011 Nov; 86(11):958-61. PubMed ID: 21948113 [No Abstract] [Full Text] [Related]
36. Current knowledge in the management of children and adolescents with sickle cell disease: Part 1, Physiological issues. Simon K; Lobo ML; Jackson S J Pediatr Nurs; 1999 Oct; 14(5):281-95. PubMed ID: 10554441 [TBL] [Abstract][Full Text] [Related]
37. The morbidity and mortality of end stage renal disease in sickle cell disease. Viner M; Zhou J; Allison D; Han J; Molokie RE; Jain S; Gowhari M; Gordeuk VR; Calip G; Saraf SL Am J Hematol; 2019 May; 94(5):E138-E141. PubMed ID: 30773675 [No Abstract] [Full Text] [Related]
38. Treatment of pain in adults with sickle cell disease. Ballas SK Am J Hematol; 1990 May; 34(1):49-54. PubMed ID: 2183594 [TBL] [Abstract][Full Text] [Related]
39. The management of pain in children with sickle cell disease. Scott RB Prog Clin Biol Res; 1982; 98():47-58. PubMed ID: 7146021 [No Abstract] [Full Text] [Related]